Annual Shareholders Equity
-$25.63 M
-$15.57 M-154.76%
December 31, 2023
Summary
- As of February 7, 2025, RAPP annual stockholders equity is -$25.63 million, with the most recent change of -$15.57 million (-154.76%) on December 31, 2023.
- During the last 3 years, RAPP annual shareholders equity has fallen by -$15.57 million (-154.76%).
- RAPP annual shareholders equity is now -154.76% below its all-time high of -$10.06 million, reached on December 31, 2022.
Performance
RAPP Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$323.11 M
-$13.77 M-4.09%
September 30, 2024
Summary
- As of February 7, 2025, RAPP quarterly stockholders equity is $323.11 million, with the most recent change of -$13.77 million (-4.09%) on September 30, 2024.
- Over the past year, RAPP quarterly shareholders equity has increased by +$362.75 million (+915.27%).
- RAPP quarterly shareholders equity is now -4.09% below its all-time high of $336.89 million, reached on June 30, 2024.
Performance
RAPP Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
RAPP Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -154.8% | +915.3% |
| 3 y3 years | -154.8% | - |
| 5 y5 years | -154.8% | - |
RAPP Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -154.8% | at low | -4.1% | +915.3% |
| 5 y | 5-year | -154.8% | at low | -4.1% | +915.3% |
| alltime | all time | -154.8% | at low | -4.1% | +915.3% |
Rapport Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $323.11 M(-4.1%) |
| Jun 2024 | - | $336.89 M(-950.0%) |
| Mar 2024 | - | -$39.63 M |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | -$25.63 M(+154.8%) | - |
| Dec 2023 | - | -$25.63 M |
| Dec 2022 | -$10.06 M | - |
FAQ
- What is Rapport Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Rapport Therapeutics?
- What is Rapport Therapeutics annual shareholders equity year-on-year change?
- What is Rapport Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Rapport Therapeutics?
- What is Rapport Therapeutics quarterly shareholders equity year-on-year change?
What is Rapport Therapeutics annual stockholders equity?
The current annual shareholders equity of RAPP is -$25.63 M
What is the all time high annual shareholders equity for Rapport Therapeutics?
Rapport Therapeutics all-time high annual stockholders equity is -$10.06 M
What is Rapport Therapeutics annual shareholders equity year-on-year change?
Over the past year, RAPP annual stockholders equity has changed by -$15.57 M (-154.76%)
What is Rapport Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of RAPP is $323.11 M
What is the all time high quarterly shareholders equity for Rapport Therapeutics?
Rapport Therapeutics all-time high quarterly stockholders equity is $336.89 M
What is Rapport Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, RAPP quarterly stockholders equity has changed by +$362.75 M (+915.27%)